Zenas BioPharma, Inc.

ZBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.2B · 167 employees
33
SEC Filings
$32.92
Close 2026-09-03
167
Employees

Business Summary

Zenas BioPharma is a clinical-stage global biopharmaceutical company focused on immunology and inflammation (I&I). Its lead candidate, obexelimab, is a bifunctional monoclonal antibody targeting CD19 and FcRIIb for autoimmune diseases including IgG4-RD, RMS, and SLE. It also develops orelabrutinib (BTK inhibitor for progressive MS), ZB021 (oral IL-17 inhibitor), ZB022 (oral TYK2-JH2 inhibitor), and other early-stage I&I programs.

Latest Stock Quote

ZBIO 2026-09-03 $32.92 O:$33.42 H:$33.66 L:$32.365 Vol:0.5M VWAP:$32.9741
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001104659-26-027964EDGAR131K words
2025-03-112024-12-310001558370-25-002631EDGAR116K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001104659-26-095448EDGAR36K words
2025-11-122025-09-300001104659-25-109753EDGAR73K words
2025-08-122025-06-300001558370-25-011147EDGAR68K words
2025-05-152025-03-310001558370-25-007803EDGAR65K words
2024-11-122024-09-300001558370-24-015162EDGAR70K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001104659-26-095437EDGAR5K words
2026-03-310001104659-26-037821EDGAR42K words
2026-03-160001104659-26-027961EDGAR4K words
2026-02-130001104659-26-015314EDGAR3K words
2026-01-050001104659-26-000402EDGAR3K words
2025-12-150001104659-25-121182EDGAR9K words
2025-11-120001104659-25-109737EDGAR3K words
2025-10-270001104659-25-102317EDGAR2K words
2025-10-080001104659-25-097663EDGAR7K words
2025-09-020001104659-25-085982EDGAR2K words

33 total filings indexed. 16 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

autoimmune-diseases immunology-and-inflammation-(i&i) multiple-sclerosis igg4-related-disease systemic-lupus-erythematosus biopharmaceuticals

Company Identity

CIK0001953926
TickerZBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.zenasbio.com
Listed2024-09-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 397bf661991140f720b768241f7e188ea23d49ddd4151adb5f80106dc319887b
parent: 925d5dc82cccb8e825a8af9b4a63693930b87e10ad18c1d3d93b5605f10407ee
content hash: 0805d907a9f186749486fbd993fe102dfb356130c6b22d2a7df586d4ead70dfd
signed: 2026-09-28T19:03:41.431Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ZBIO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ZBIO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ZBIO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.